𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tourist hepatitis, antibodies to hepatitis a virus and immune serum globulin prophylaxis

✍ Scribed by S. Iwarson; G. Norkrans; G. Frösner

Publisher
Springer-Verlag
Year
1978
Tongue
English
Weight
282 KB
Volume
6
Category
Article
ISSN
0300-8126

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antibodies to Hepatitis A Virus in Immun
Antibodies to Hepatitis A Virus in Immune Serum Globulin
✍ L. A. Smallwood; E. Tabor; J. S. Finlayson; MD; PhD R. J. Gerety 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB

## Abstract Two hundred one immune serum globulin (ISG) lots manufactured in the US between 1967 and 1977 were tested for antibodies to the hepatitis A virus (anti‐HAV) by a competitive‐inhibition radioimmunoassay (RIA); a lesser number were also tested by immune adherence hemagglutination (IAHA).

Hepatitis B virus envelope variation aft
Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis
✍ W F Carman; C Trautwein; J van Deursen; K Colman; E Dornan; G McIntyre; J Waters 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB 👁 1 views

cleoside analogues, 8-10 the only established treatment option Hepatitis B virus (HBV) replicates via an intermediate to prevent reinfection is the administration of polyclonal hep-RNA step. High frequency of polymerase errors with adatitis B surface antigen antibody (anti-HBs) (hepatitis B imdition

Hepatitis B virus S mutants in liver tra
Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis
✍ Marc G. Ghany; Brick Ayola; Federico G. Villamil; Robert G. Gish; Sergio Rojter; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 1 views

## Long -term hepatitis B immune globulin (HBIG) has been shown to reduce hepatitis B virus (HBV) reinfection in patients transplanted for hepatitis B. The aim of this study was to determine the prevalence of HBV S gene mutations in liver transplant recipients who developed recurrent hepatitis B d

Monoclonal antibodies to hepatitis A vir
Monoclonal antibodies to hepatitis A virus
✍ George J. Dawson; Richard H. Decker; Debra K. Norton; Warren H. Bryce; Richard O 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 477 KB

This paper describes the development of monoclonal antibodies generated against hepatitis A virus (HAV). Monoclonal antibodies (MCABs) from two murine hybridoma cell lines were found to bind to an epitope recognized in the sera of patients recovering from infection with HAV. Ascites fluids containin

Prophylaxis against hepatitis B recurren
Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin
✍ Jay S. Markowitz; Paul Martin; Andrew J. Conrad; James F. Markmann; Philip Seu; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

Patients undergoing liver transplantation for hepatitis B-related liver disease are prone to recurrence. The mainstay of prophylaxis has been passive immunotherapy with hepatitis B immune globulin (HBIG). Antiviral therapy with lamivudine has proven effective in lowering hepatitis B virus (HBV) DNA